APPLICATION
ANDA085200
TYPE
ANDA
ORIGINAL APPROVAL
1981-03-13
LATEST ACTION
1995-04-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
IMIPRAMINE HYDROCHLORIDEDiscontinued
IMIPRAMINE HYDROCHLORIDE 10MG · TABLET · ORAL
Approval history
1995-04-20Labeling · Supplement 14AP
1993-06-25Labeling · Supplement 13AP
1993-03-12Labeling · Supplement 12AP
1992-07-31Labeling · Supplement 11AP
1989-04-26Labeling · Supplement 9AP
1988-08-22Bioequivalence · Supplement 1AP
1983-02-22Manufacturing (CMC) · Supplement 5AP
1983-02-22Manufacturing (CMC) · Supplement 4AP
1981-03-13OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.